Menopause Tech Boom: Experts Warn of 'Gold Rush' Amid Unregulated Market
In an era where wearable technology monitors everything from heart rates to sleep patterns, a new frontier is emerging: devices aimed at alleviating menopausal symptoms. This burgeoning market, projected to reach approximately $24 billion globally by 2030, is attracting significant investment from venture capital funds and corporate giants like Bayer and Unilever Ventures. However, experts are raising alarms about a potential "menopause gold rush," where unregulated companies may exploit women's fears with overhyped solutions.
The Rise of Menopause-Focused Wearables
The march of wearable tech is now addressing what many describe as a long underserved demographic: menopausal women. Startups are launching innovative products, such as high-end cooling bracelets that activate during hot flushes, alongside apps offering dietary advice and devices tracking symptoms, hormones, and body temperature. This growth coincides with a reduction in stigma surrounding menopause, encouraging more open discussions and product development.
One notable example is the MyCelsius bracelet, priced at £229.99, which is worn on the wrist to provide instant cooling for hot flushes. Its designers claim it also helps mitigate effects of hormonal changes, including stress and anxiety. Sarah Garlick, a 50-year-old who entered surgical menopause after a hysterectomy, found relief through this device after trying various other products. She attributes the increased marketing of such items to the shifting cultural attitudes towards menopause, noting her willingness to discuss her experiences openly with other women.
Investment Surge and Scrutiny Concerns
With increased investment comes heightened scrutiny. A recent study by University College London, led by Professor Joyce Harper, warned of unregulated companies capitalising on a lack of reliable information. Researchers emphasised the need for a national education programme, as many women feel inadequately informed about menopause. Maxime Kryvian, co-founder of Celsius Innovations, acknowledges the scepticism surrounding new products, citing the supplement market as an example where impact can be hard to attribute. He stresses the importance of scientific backing and expert involvement in product development.
Kryvian advises consumers to scrutinise product claims by asking key questions: "How was this developed, and by whom? Is there data on its impact? What do customer reviews say?" He also suggests looking for companies that offer reimbursement if products fail, viewing this as a strong indicator of credibility.
Expert Caution and Evidence-Based Advice
Dr Claire Phipps, a menopause specialist at London Gynaecology, recognises the potential benefits of wearable tech but urges caution. She warns against rushing to purchase products marketed as "menopause relief" without solid evidence, highlighting a significant lack of randomised controlled trials in this area. Phipps points out that, unlike fertility care, menopause has fewer regulatory safeguards, making it difficult for women to discern trustworthy sources.
"The industry is booming, but there's still a huge lack of randomised controlled trials. If a product hasn't been properly tested, how do we know it works?" Phipps questions. She advocates for a grounded approach, starting with basic lifestyle changes like nutrition, self-care, and stress management. For cooling solutions, she surprisingly recommends a simple handheld fan as potentially the best option, emphasising practicality over high-tech gadgets.
The Challenge of Misinformation and Future Directions
The rapid expansion of the "menopause economy" has led to a proliferation of misinformation, often propagated by social media influencers. Phipps condemns the spread of exaggerated claims, calling it "shameful" and urging a focus on evidence-based solutions. She advises women to seek professional guidance if symptoms persist, rather than relying solely on unverified products.
As the market continues to grow, the balance between innovation and consumer protection remains critical. With nearly two-thirds of women over 50 in the UK reporting struggles with mental health and other issues during menopause, the demand for effective solutions is clear. However, experts unanimously stress the need for rigorous science and transparent information to navigate this evolving landscape safely.
